{
  "prompt": {
    "prompt": "Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\n\nFor each recommendation, specify:\n1. The type of recommendation:\n   - Additional information needed (history/examination/investigations)\n   - Improved patient advice (options/statistics/patient information)\n   - Different management plan\n2. The specific recommendation\n3. The reason for the recommendation (referencing the guideline)\n\nCategorize each recommendation by importance:\n- Very Important: Critical for patient safety or guideline compliance\n- Somewhat Important: Significant for optimal care but not critical\n- Less Important: Would improve care but not essential\n- Unimportant: Minor suggestions that could be considered\n\nFormat the response as follows:\n\n### Very Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Somewhat Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Less Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Unimportant Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\nClinical Note:\nSITUATION: 35-year-old G4P2+1 at 28+5 weeks gestation with major placenta previa and recent bleeding episode requiring management\n\nBACKGROUND: Mrs Ahmed has known complete placenta previa diagnosed at 20-week anomaly scan, where placenta was noted to completely cover the cervical os. She has been managed with pelvic rest and regular monitoring. Yesterday evening she experienced sudden onset bright red vaginal bleeding, described as 'heavy like a heavy period' lasting approximately 20 minutes before settling. No associated pain, no contractions, good fetal movements felt. This is her second bleeding episode - first was at 24 weeks requiring overnight observation. Obstetric history: 2 previous caesarean sections (emergency then elective), 1 first trimester miscarriage requiring ERPC. Significant risk factors for placenta previa include previous uterine surgery and maternal age. She has been compliant with activity restrictions and regular antenatal care.\n\nASSESSMENT: On examination, patient appears well, slightly anxious about bleeding. Vital signs stable: BP 118/72 mmHg, HR 88 bpm, temp 36.6°C. Abdomen soft, non-tender, fundal height 29cm. No current bleeding visible, small clots in pad from earlier episode. No abdominal pain or uterine tenderness. CTG shows reassuring fetal heart rate pattern with baseline 145 bpm, good variability, no decelerations. Recent ultrasound confirms complete placenta previa with placental edge 0mm from internal os. No evidence of placental abruption. Hemoglobin 10.8 g/dL (down from 11.4 g/dL last month), other bloods normal. Kleihauer-Betke test negative (Rh positive mother).\n\nRECOMMENDATION: Admission for observation and surveillance given significant bleeding episode. IV access established, cross-match for 4 units of blood. Antenatal corticosteroids administered for fetal lung maturity given risk of early delivery. Strict bed rest initially, then gradual mobilization if no further bleeding. Daily monitoring with CTG and maternal observations. Serial hemoglobin monitoring. Emergency caesarean section if further significant bleeding occurs. Elective caesarean section planned for 36-37 weeks if no further complications. Anesthetic consultation arranged given high-risk nature and potential for emergency delivery. Blood transfusion service informed of high-risk patient.\n\nGuideline:\n[ID] gtg-2011-aph-pdf\nTitle: GTG 2011 - APH.pdf\nContent: Antepartum Haemorrhage\nAntepartum haemorrhage (APH) is defined as bleeding from or in to the genital tract, occurring from 24+0 weeks of pregnancy and prior to the birth of the baby. The most important causes of APH are placenta praevia and placental abruption. APH complicates 3–5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Up to one-fifth of very preterm babies are born in association with APH, and the known association of APH with cerebral palsy can be explained by preterm delivery. Recurrent APH is the term used when there are episodes of APH on more than one occasion. It is important to assess for signs of clinical shock when estimating blood loss, as the amount of blood lost is often underestimated. Spotting, minor haemorrhage, major haemorrhage, and massive haemorrhage are defined based on the amount of blood loss. Antepartum haemorrhage is associated with maternal and perinatal morbidity and mortality. Pregnancies complicated by unexplained APH are also at increased risk of adverse maternal and perinatal outcomes. Women with repeated presentations that may include APH should be asked about domestic violence. Women with APH should report all vaginal bleeding to their antenatal care provider and be managed in a hospital maternity unit with facilities for resuscitation and emergency operative delivery.\n\nClinical assessment in women presenting with APH is crucial to establish the need for urgent intervention to manage maternal or fetal compromise. Triage includes history-taking, assessment of vaginal bleeding, maternal cardiovascular condition, and fetal wellbeing. If major haemorrhage persists or the woman is unable to provide a history, immediate maternal stabilization is priority. A full history should be taken to identify potential causes of APH, such as placental abruption or placenta praevia. Abdominal palpation and speculum examination can aid in identifying the cause of bleeding. Maternal investigations, such as blood tests and ultrasound scans, should be performed to assess the extent of APH. Fetal investigations, including fetal heart rate assessment and ultrasound scans, are important to monitor fetal wellbeing. Hospitalization is recommended for women with APH heavier than spotting or ongoing bleeding. Antenatal corticosteroids may be considered for women at risk of preterm birth. Tocolytic therapy should not be used in cases of major APH or placental abruption. Antenatal care should be altered following APH, with increased fetal surveillance for high-risk pregnancies. Delivery should be determined based on maternal and fetal condition, with immediate delivery required for compromised cases.\n\nIn women with antepartum hemorrhage (APH) due to placenta praevia, management includes maternal resuscitation and delivery of the fetus to control bleeding. Delivery is usually by caesarean section in cases of maternal or fetal compromise. For women with APH before 37 weeks of gestation without compromise, elective premature delivery is not recommended. In cases after 37 weeks, induction of labor may be considered. Fetal monitoring during labor should be continuous for active bleeding or if there are concerns of placental insufficiency. Regional anesthesia is recommended for operative delivery in cases of APH, unless contraindicated. Postpartum hemorrhage should be anticipated and active management of the third stage of labor is recommended. Anti-D Ig should be given to RhD-negative women after any presentation with APH. Massive APH should be managed following multidisciplinary protocols, and blood products should be ordered as needed. Women with coagulopathy should receive appropriate transfusions. Neonates should be assessed by a senior pediatrician/neonatologist in cases of major APH. In cases of extremely preterm pregnancy with APH, maternal stabilization is the priority before considering delivery of the baby. Postnatal issues include thromboprophylaxis, debriefing, and clinical incident reporting. Obstetric skill drills should include management of major APH to improve patient safety.\n\nteamworking and ensure prompt and efficient management in such an emergency.\nSuggested audit topics:\n1. The administration of corticosteroids to women presenting with APH less than 34+6weeks of gestation.\n2. Administration of anti-D Ig to non-sensitised RhD-negative women presenting with APH.\n3. Percentage of women with APH referred for serial growth scans.\n4. Management of the third stage of labour in women who had a major APH.\n5. Appropriate training of the multidisciplinary team.\n\nAreas for future research:\n1. Randomised controlled trials of interventions to prevent placental abruption.\n2. Studies to determine the optimum timing of delivery in women presenting with unexplained APH.\n3. Studies to determine maternal and fetal outcomes following the use of blood products in the management of APH.\n\nPrinciples of management of massive APH (blood loss greater than 1000 ml and/or signs of clinical shock)\nPersonnel required:\n- Call experienced midwife, obstetric middle grade, alert consultant, and clinical hematologist\n- Alert blood transfusion laboratory\n- Designate a team member to record events, fluids, drugs, and vital signs.\nInitial management:\n- Follow the ABCD pathway (Assess airway, breathing, circulation, and decide on delivery)\nThe four pillars of management:\n- Communication between all team members\n- Resuscitation\n- Monitoring and investigation\n- Arrest bleeding by arranging delivery of the fetus\nManagement strategies adapted from RCOG Green-top Guideline No. 52 Prevention and Management of Postpartum Haemorrhage\nDifferences in management options between APH and PPH\n- Delivery of the fetus and placenta to control bleeding and prevent DIC\nPrinciples of fluid replacement and administration of blood products:\n- Basic measures for haemorrhage up to 1000 ml with no clinical shock\n- Full protocol for massive haemorrhage (blood loss > 1000 ml or clinical shock)\nFluid therapy and blood product transfusion guidelines\nMain therapeutic goal: maintain specific levels of hemoglobin, platelets, prothrombin time, activated partial prothromboplastin time, and fibrinogen.",
    "system_prompt": "You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.",
    "guideline_id": "gtg-2011-aph-pdf",
    "guideline_title": "GTG 2011 - APH.pdf"
  },
  "response": "Here is the analysis of the clinical note against the provided guideline (GTG 2011 - APH) with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document whether domestic violence screening was performed given recurrent APH.  \n   Reason: The guideline emphasizes that women with repeated presentations of APH should be asked about domestic violence (GTG 2011 - APH, Clinical Assessment section).  \n\n2. **Different management plan** - Consider administering anti-D immunoglobulin (if not already done, though note states Rh-positive mother).  \n   Reason: The guideline recommends anti-D Ig for RhD-negative women after any APH presentation (GTG 2011 - APH, Management Principles section). While this patient is Rh-positive, explicitly stating this avoids ambiguity.  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide clearer counseling on the risks of recurrent bleeding, preterm delivery, and potential need for emergency delivery.  \n   Reason: The guideline highlights the association of APH with adverse perinatal outcomes (GTG 2011 - APH, Introduction). Patient understanding of risks is crucial for informed decision-making.  \n\n2. **Additional information needed** - Document a detailed plan for thromboprophylaxis given bed rest and high-risk status (previous C-sections, placenta previa).  \n   Reason: The guideline mentions postnatal thromboprophylaxis but does not explicitly address antenatal prophylaxis. However, given immobilization, this is a significant consideration.  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Include a documented anesthetic plan (e.g., preference for regional anesthesia if no contraindications).  \n   Reason: The guideline recommends regional anesthesia for operative delivery in APH unless contraindicated (GTG 2011 - APH, Management Principles). While an anesthetic consult was arranged, specifics would improve clarity.  \n\n2. **Improved patient advice** - Discuss long-term implications (e.g., future pregnancy risks, need for elective C-sections).  \n   Reason: The guideline focuses on acute management but does not explicitly address long-term counseling. This would enhance patient-centered care.  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Consider documenting a debriefing plan post-delivery.  \n   Reason: The guideline mentions debriefing as a postnatal issue (GTG 2011 - APH, Postnatal section), but this is less critical for the acute note.  \n\n### Summary of Key Improvements:  \n- Explicitly address domestic violence screening.  \n- Clarify anti-D Ig administration (though not needed here).  \n- Enhance patient counseling on risks and long-term implications.  \n- Document thromboprophylaxis and anesthetic plans in more detail.  \n\nOverall, the note is well-aligned with the guideline but could be strengthened in these areas.",
  "endpoint": "analyzeNoteAgainstGuideline",
  "timestamp": "2025-06-26T14-48-50",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"prompt\": \"Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\\n\\nFor each recommendation, specify:\\n1. The type of recommendation:\\n   - Additional information needed (history/examination/investigations)\\n   - Improved patient advice (options/statistics/patient information)\\n   - Different management plan\\n2. The specific recommendation\\n3. The reason for the recommendation (referencing the guideline)\\n\\nCategorize each recommendation by importance:\\n- Very Important: Critical for patient safety or guideline compliance\\n- Somewhat Important: Significant for optimal care but not critical\\n- Less Important: Would improve care but not essential\\n- Unimportant: Minor suggestions that could be considered\\n\\nFormat the response as follows:\\n\\n### Very Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Somewhat Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Less Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Unimportant Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\nClinical Note:\\nSITUATION: 35-year-old G4P2+1 at 28+5 weeks gestation with major placenta previa and recent bleeding episode requiring management\\n\\nBACKGROUND: Mrs Ahmed has known complete placenta previa diagnosed at 20-week anomaly scan, where placenta was noted to completely cover the cervical os. She has been managed with pelvic rest and regular monitoring. Yesterday evening she experienced sudden onset bright red vaginal bleeding, described as 'heavy like a heavy period' lasting approximately 20 minutes before settling. No associated pain, no contractions, good fetal movements felt. This is her second bleeding episode - first was at 24 weeks requiring overnight observation. Obstetric history: 2 previous caesarean sections (emergency then elective), 1 first trimester miscarriage requiring ERPC. Significant risk factors for placenta previa include previous uterine surgery and maternal age. She has been compliant with activity restrictions and regular antenatal care.\\n\\nASSESSMENT: On examination, patient appears well, slightly anxious about bleeding. Vital signs stable: BP 118/72 mmHg, HR 88 bpm, temp 36.6°C. Abdomen soft, non-tender, fundal height 29cm. No current bleeding visible, small clots in pad from earlier episode. No abdominal pain or uterine tenderness. CTG shows reassuring fetal heart rate pattern with baseline 145 bpm, good variability, no decelerations. Recent ultrasound confirms complete placenta previa with placental edge 0mm from internal os. No evidence of placental abruption. Hemoglobin 10.8 g/dL (down from 11.4 g/dL last month), other bloods normal. Kleihauer-Betke test negative (Rh positive mother).\\n\\nRECOMMENDATION: Admission for observation and surveillance given significant bleeding episode. IV access established, cross-match for 4 units of blood. Antenatal corticosteroids administered for fetal lung maturity given risk of early delivery. Strict bed rest initially, then gradual mobilization if no further bleeding. Daily monitoring with CTG and maternal observations. Serial hemoglobin monitoring. Emergency caesarean section if further significant bleeding occurs. Elective caesarean section planned for 36-37 weeks if no further complications. Anesthetic consultation arranged given high-risk nature and potential for emergency delivery. Blood transfusion service informed of high-risk patient.\\n\\nGuideline:\\n[ID] gtg-2011-aph-pdf\\nTitle: GTG 2011 - APH.pdf\\nContent: Antepartum Haemorrhage\\nAntepartum haemorrhage (APH) is defined as bleeding from or in to the genital tract, occurring from 24+0 weeks of pregnancy and prior to the birth of the baby. The most important causes of APH are placenta praevia and placental abruption. APH complicates 3–5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Up to one-fifth of very preterm babies are born in association with APH, and the known association of APH with cerebral palsy can be explained by preterm delivery. Recurrent APH is the term used when there are episodes of APH on more than one occasion. It is important to assess for signs of clinical shock when estimating blood loss, as the amount of blood lost is often underestimated. Spotting, minor haemorrhage, major haemorrhage, and massive haemorrhage are defined based on the amount of blood loss. Antepartum haemorrhage is associated with maternal and perinatal morbidity and mortality. Pregnancies complicated by unexplained APH are also at increased risk of adverse maternal and perinatal outcomes. Women with repeated presentations that may include APH should be asked about domestic violence. Women with APH should report all vaginal bleeding to their antenatal care provider and be managed in a hospital maternity unit with facilities for resuscitation and emergency operative delivery.\\n\\nClinical assessment in women presenting with APH is crucial to establish the need for urgent intervention to manage maternal or fetal compromise. Triage includes history-taking, assessment of vaginal bleeding, maternal cardiovascular condition, and fetal wellbeing. If major haemorrhage persists or the woman is unable to provide a history, immediate maternal stabilization is priority. A full history should be taken to identify potential causes of APH, such as placental abruption or placenta praevia. Abdominal palpation and speculum examination can aid in identifying the cause of bleeding. Maternal investigations, such as blood tests and ultrasound scans, should be performed to assess the extent of APH. Fetal investigations, including fetal heart rate assessment and ultrasound scans, are important to monitor fetal wellbeing. Hospitalization is recommended for women with APH heavier than spotting or ongoing bleeding. Antenatal corticosteroids may be considered for women at risk of preterm birth. Tocolytic therapy should not be used in cases of major APH or placental abruption. Antenatal care should be altered following APH, with increased fetal surveillance for high-risk pregnancies. Delivery should be determined based on maternal and fetal condition, with immediate delivery required for compromised cases.\\n\\nIn women with antepartum hemorrhage (APH) due to placenta praevia, management includes maternal resuscitation and delivery of the fetus to control bleeding. Delivery is usually by caesarean section in cases of maternal or fetal compromise. For women with APH before 37 weeks of gestation without compromise, elective premature delivery is not recommended. In cases after 37 weeks, induction of labor may be considered. Fetal monitoring during labor should be continuous for active bleeding or if there are concerns of placental insufficiency. Regional anesthesia is recommended for operative delivery in cases of APH, unless contraindicated. Postpartum hemorrhage should be anticipated and active management of the third stage of labor is recommended. Anti-D Ig should be given to RhD-negative women after any presentation with APH. Massive APH should be managed following multidisciplinary protocols, and blood products should be ordered as needed. Women with coagulopathy should receive appropriate transfusions. Neonates should be assessed by a senior pediatrician/neonatologist in cases of major APH. In cases of extremely preterm pregnancy with APH, maternal stabilization is the priority before considering delivery of the baby. Postnatal issues include thromboprophylaxis, debriefing, and clinical incident reporting. Obstetric skill drills should include management of major APH to improve patient safety.\\n\\nteamworking and ensure prompt and efficient management in such an emergency.\\nSuggested audit topics:\\n1. The administration of corticosteroids to women presenting with APH less than 34+6weeks of gestation.\\n2. Administration of anti-D Ig to non-sensitised RhD-negative women presenting with APH.\\n3. Percentage of women with APH referred for serial growth scans.\\n4. Management of the third stage of labour in women who had a major APH.\\n5. Appropriate training of the multidisciplinary team.\\n\\nAreas for future research:\\n1. Randomised controlled trials of interventions to prevent placental abruption.\\n2. Studies to determine the optimum timing of delivery in women presenting with unexplained APH.\\n3. Studies to determine maternal and fetal outcomes following the use of blood products in the management of APH.\\n\\nPrinciples of management of massive APH (blood loss greater than 1000 ml and/or signs of clinical shock)\\nPersonnel required:\\n- Call experienced midwife, obstetric middle grade, alert consultant, and clinical hematologist\\n- Alert blood transfusion laboratory\\n- Designate a team member to record events, fluids, drugs, and vital signs.\\nInitial management:\\n- Follow the ABCD pathway (Assess airway, breathing, circulation, and decide on delivery)\\nThe four pillars of management:\\n- Communication between all team members\\n- Resuscitation\\n- Monitoring and investigation\\n- Arrest bleeding by arranging delivery of the fetus\\nManagement strategies adapted from RCOG Green-top Guideline No. 52 Prevention and Management of Postpartum Haemorrhage\\nDifferences in management options between APH and PPH\\n- Delivery of the fetus and placenta to control bleeding and prevent DIC\\nPrinciples of fluid replacement and administration of blood products:\\n- Basic measures for haemorrhage up to 1000 ml with no clinical shock\\n- Full protocol for massive haemorrhage (blood loss > 1000 ml or clinical shock)\\nFluid therapy and blood product transfusion guidelines\\nMain therapeutic goal: maintain specific levels of hemoglobin, platelets, prothrombin time, activated partial prothromboplastin time, and fibrinogen.\",\n  \"system_prompt\": \"You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.\",\n  \"guideline_id\": \"gtg-2011-aph-pdf\",\n  \"guideline_title\": \"GTG 2011 - APH.pdf\"\n}\n\nA: Here is the analysis of the clinical note against the provided guideline (GTG 2011 - APH) with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document whether domestic violence screening was performed given recurrent APH.  \n   Reason: The guideline emphasizes that women with repeated presentations of APH should be asked about domestic violence (GTG 2011 - APH, Clinical Assessment section).  \n\n2. **Different management plan** - Consider administering anti-D immunoglobulin (if not already done, though note states Rh-positive mother).  \n   Reason: The guideline recommends anti-D Ig for RhD-negative women after any APH presentation (GTG 2011 - APH, Management Principles section). While this patient is Rh-positive, explicitly stating this avoids ambiguity.  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide clearer counseling on the risks of recurrent bleeding, preterm delivery, and potential need for emergency delivery.  \n   Reason: The guideline highlights the association of APH with adverse perinatal outcomes (GTG 2011 - APH, Introduction). Patient understanding of risks is crucial for informed decision-making.  \n\n2. **Additional information needed** - Document a detailed plan for thromboprophylaxis given bed rest and high-risk status (previous C-sections, placenta previa).  \n   Reason: The guideline mentions postnatal thromboprophylaxis but does not explicitly address antenatal prophylaxis. However, given immobilization, this is a significant consideration.  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Include a documented anesthetic plan (e.g., preference for regional anesthesia if no contraindications).  \n   Reason: The guideline recommends regional anesthesia for operative delivery in APH unless contraindicated (GTG 2011 - APH, Management Principles). While an anesthetic consult was arranged, specifics would improve clarity.  \n\n2. **Improved patient advice** - Discuss long-term implications (e.g., future pregnancy risks, need for elective C-sections).  \n   Reason: The guideline focuses on acute management but does not explicitly address long-term counseling. This would enhance patient-centered care.  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Consider documenting a debriefing plan post-delivery.  \n   Reason: The guideline mentions debriefing as a postnatal issue (GTG 2011 - APH, Postnatal section), but this is less critical for the acute note.  \n\n### Summary of Key Improvements:  \n- Explicitly address domestic violence screening.  \n- Clarify anti-D Ig administration (though not needed here).  \n- Enhance patient counseling on risks and long-term implications.  \n- Document thromboprophylaxis and anesthetic plans in more detail.  \n\nOverall, the note is well-aligned with the guideline but could be strengthened in these areas.\n\n--- Token Usage Report ---\nPrompt tokens: 1978\nCompletion tokens: 574\nTotal tokens: 2552\nEstimated cost: $0.001276",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": {
    "prompt_tokens": 1978,
    "completion_tokens": 574,
    "total_tokens": 2552,
    "estimated_cost_usd": 0.001276
  }
}